Response to treatment in bipolar disorder

Current Opinion in Psychiatry

Volumn 24, Issue 1, 2011, Pages 24-28

  Cruceanu, Cristiana ^a   Alda, Martin ^b   Rouleau, Guy ^c   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

bipolar disorder; genetics; GWAS; lithium

Indexed keywords

ARTICLE; BIPOLAR DISORDER; FAMILY HISTORY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPRECIPITATION; TREATMENT RESPONSE;

ANTIMANIC AGENTS; BIPOLAR DISORDER; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LITHIUM COMPOUNDS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 78650526332     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328341352c     Document Type: Article

References (48)

1. Alda M, Hajek T, Calkin C, ODonovan C. Treatment of bipolar disorder: new perspectives. Ann Med 2009; 41:186-196.
2. Cruceanu C, Alda M, Turecki G. Lithium: a key to the genetics of bipolar disorder. Genome Med 2009; 1:79.
3. Cruceanu C, Lopez de Lara C, Alda M, Turecki G. Pharmacogenetics of lithium response. Psychiatric Ann Online [Review] 2008; 38:1-6.
4. Craddock N, Sklar P. Genetics of bipolar disorder: successful start to a long journey. Trends Genet 2009; 25:99-105.
5. Schulze TG. Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. Psychiatr Clin North Am 2010; 33:67-82.
6. Grof P. Sixty years of lithium responders. Neuropsychobiology 2010; 62:8-16.
7. Grof P, Alda M, Grof E, et al. Lithium response and genetics of affective disorders. J Affect Disord 1994; 32:85-95.
8. Grof P, Duffy A, Cavazzoni P, et al. Is response to prophylactic lithiuma familial trait? J Clin Psychiatry 2002; 63:942-947.
9. Rybakowski JK. Lithium: sixty years thereafter. Neuropsychobiology 2010; 62:5-7.
10. Passmore MJ, Garnham J, Duffy A, et al. Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine. Bipolar Disord 2003; 5:110-114.
11. Turecki G, Grof P, Grof E, et al. Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 2001; 6:570-578.
12. Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 1997; 54:37-42.
13. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7:405-411.
14. Segurado R, Detera-Wadleigh SD, Levinson DF, et al. Genome scan metaanalysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet 2003; 73:49-62.
15. Turecki G, Grof P, Cavazzoni P, et al. Lithium responsive bipolar disorder, unilineality, and chromosome 18: a linkage study. Am J Med Genet 1999; 88:411-415.
16. de Lara CL, Jaitovich-Groisman I, Cruceanu C, et al. Implication of synapserelated genes in bipolar disorder by linkage and gene expression analyses. Int J Neuropsychopharmacol 2010; 1-14.
17. Duffy A, Turecki G, Grof P, et al. Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. J Psychiatry Neurosci 2000; 25:353-358.
18. Mamdani F, Alda M, Grof P, et al. Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:500-504.
19. Mamdani F, Sequeira A, Alda M, et al. No association between the PREP gene and lithium responsive bipolar disorder. BMC Psychiatry 2007; 7:9.
20. Cavazzoni P, Alda M, Turecki G, et al. Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene. Psychiatry Res 1996; 64:91-96.
21. Turecki G, Alda M, Grof P, et al. No association between chromosome-18 markers and lithium-responsive affective disorders. Psychiatry Res 1996; 63:17-23.
22. Serretti A, Lilli R, Lorenzi C, et al. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry 2002; 7:95-99.
23. Adli M, Hollinde DL, Stamm T, et al. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry 2007; 62:1295-1302.
24. Sjoholt G, Ebstein RP, Lie RT, et al. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol Psychiatry 2004; 9:621-629.
25. Serretti A, Mandelli L. The genetics of bipolar disorder: genome hot regions, genes, new potential candidates and future directions. Mol Psychiatry 2008; 13:742-771.
26. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-678.
27. Baum AE, Akula N, Cabanero M, et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13:197-207.
28. Sklar P, Smoller JW, Fan J, et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 2008; 13:558-569.
29. Campos-de-Sousa S, Guindalini C, Tondo L, et al. Nuclear receptor rev-erb- {alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder. J Biol Rhythms 2010; 25:132-137.
30. Manchia M, Congiu D, Squassina A, et al. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample. Psychiatry Res 2009; 169:164-166.
31. Manchia M, Squassina A, Congiu D, et al. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. Neurosci Lett 2009; 467:67-71.
32. Szczepankiewicz A, Skibinska M, Suwalska A, et al. No association of three GRIN2B polymorphisms with lithium response in bipolar patients. Pharmacol Rep 2009; 61:448-452.
33. Szczepankiewicz A, Rybakowski JK, Skibinska M, et al. FYN kinase gene: another glutamatergic gene associated with bipolar disorder? Neuropsychobiology 2009; 59:178-183.
34. Rybakowski JK, Suwalska A, Skibinska M, et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 2005; 38:166-170.
35. Szczepankiewicz A, Skibinska M, Suwalska A, et al. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Hum Psychopharmacol 2009; 24:287-291.
36. Kim B, Kim CY, Lee MJ, Joo YH. Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders. Psychiatry Res 2009; 168:209-212.
37. Perlis RH, Adams DH, Fijal B, et al. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. J Clin Psychiatry 2010; 71:599-605.
38. Squassina A, Manchia M, Congiu D, et al. The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample. Mol Psychiatry 2009; 14:350-351.
39. Perlis RH, Smoller JW, Ferreira MA, et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. Am J Psychiatry 2009; 166:718-725.
40. Seelan RS, Khalyfa A, Lakshmanan J, et al. Deciphering the lithium transcriptome: microarray profiling of lithium-modulated gene expression in human neuronal cells. Neuroscience 2008; 151:1184-1197.
41. Schulze TG, Alda M, Adli M, et al. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 2010; 62:72-78.
42. Pedrosa E, Shah A, Tenore C, et al. Beta-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network. J Neurogenet 2010. [Epub ahead of print]
43. King J, Keim M, Teo R, et al.Genetic control of lithium sensitivity and regulation of inositol biosynthetic genes. PLoS One 2010; 13:1355-1368.
44. Kubota M, Kasahara T, Iwamoto K, et al. Therapeutic implications of downregulation of cyclophilin D in bipolar disorder. Int J Neuropsychopharmacol 2010; 13:1355-1368.
45. Zhou R, Yuan P, Wang Y, et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009; 34:1395-1405.
46. Chen H, Wang N, Burmeister M, McInnis MG. MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol 2009; 2:1-7.
47. Rong H, Liu TB, Yang KJ, et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res 2010. [Epub ahead of print]
48. Grof P, Duffy A, Alda M, Hajek T. Lithium response across generations. Acta Psychiatr Scand 2009; 120:378-385.